Navigation Links
2-Day Seminar FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials by Ex-FDA Official (Tampa, FL, United States - May 18-19, 2017) - Research and Markets
Date:4/8/2017

DUBLIN, April 7, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials: 2-Day In-Person Seminar by Ex-FDA Official" conference to their offering.

Because a phase 1 clinical trial initially introduces an investigational new drug into human subjects, appropriate CGMP help ensure subject safety. It is important to implement quality control (QC) principles to the manufacture of phase 1 investigational drugs (i.e., interpreting and implementing CGMP consistent with good scientific methodology), which foster CGMP activities that are more appropriate for phase 1 clinical trials, improve the quality of phase 1 investigational drugs, and facilitate the initiation of investigational clinical trials in humans while continuing to protect trial subjects.

The following steps to establish the appropriate manufacturing environment for phase 1 investigational drugs should be taken: 

- A comprehensive and systematic evaluation of the manufacturing setting (i.e., product environment, equipment, process, personnel, materials) to identify potential hazards
- Appropriate actions prior to and during manufacturing to eliminate or mitigate potential hazards to safeguard the quality of the phase 1 investigational drug

Review the FDA recommendations and requirements for implementing a compliant program for the phase 1 clinical program.

The following topics will be discussed to provide the foundation and basis for advancing drugs into clinical development from research and providing required information to the FDA regarding these products.

- Overview of Good Manufacturing Practices
- GMP Requirements for a Phase 1 Study
- Personnel
- QC Function
- Facility and Equipment
- Control of components, containers and closures
- Manufacturing & Records
- Laboratory Controls
- Vendor selection & management
- Process Validation
- Special Considerations
- Multi-product facilities
- Biologics
- Sterile products
- Combination products
- Providing relevant information in the IND application

Course benefit:

This workshop will review the current regulations, guidance documents for early stage manufacturing and GMPs in detail. Regulatory strategies and logistical considerations for early development stage product, including vendor selection and management, stability, labeling, and documentation requirements will also be reviewed and explored.

Learning Objectives:

To gain an understanding of the requirements for drugs entering into phase 1 clinical development and the minimum FDA requirements for phase I GMPs. To learn practical applications for implementing manufacturing and quality strategies to meet FDA requirements.

Areas Covered:

Day 1 Topics

- Overview of GMP requirements
- GMP Requirements for a Phase 1 Study
- Personnel documentation and requirements
- QC Function procedures and requirements
- Facility and Equipment requirements
- Control of components, containers and closures - methods and specs
- Manufacturing & Records during phase 1 studies with an eye toward later development

Day 2 Topics

- Vendor selection & management
- Process Validation to conduct for phase 1 clinical supply process
- Specific requirements for various types of products: biologics, combinations, sterile products
- Multi-product facilities considerations
- Preparing relevant SOPs for early stage development
- Providing relevant information in the IND application

For more information about this conference visit http://www.researchandmarkets.com/research/24fd6x/fdas_gmp

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/2-day-seminar-fdas-gmp-expectations-for-phase-i-and-first-in-man-clinical-trials-by-ex-fda-official-tampa-fl-united-states---may-18-19-2017---research-and-markets-300436530.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. ComplianceOnline Announces Seminar on Pharmacovigilance Audit Strategy Planning
2. Online Seminar on Crystallization Scale-up From METTLER TOLEDO
3. ComplianceOnline Announces Seminar on FDA Regulation of Regenerative Medicine
4. Former Senior FDA Official to Conduct Popular ComplianceOnline Seminar on the FDA’s Import Program
5. ComplianceOnline Announces Seminar on Medical Device Risk Management
6. ComplianceOnline Announces Popular Seminar on Effective Quality Oversight of Pharmaceutical CMOs
7. ComplianceOnline Announces On-Demand Seminar on Advertising and Promotional Requirements for Drugs and Medical Devices
8. ComplianceOnline Announces Seminar on Latin America: Regulatory Compliance Requirements for Life Science Products (Focus: Brazil, Mexico, Argentina)
9. ComplianceOnline Announces Seminar on Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions
10. Complimentary Educational Seminar for Keratoconus Patients at Corneal Associates of New Jersey
11. Texas Fertility Center Offers Complementary Egg Freezing Seminars
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/6/2019)... ... August 06, 2019 , ... The San Diego ... launching the biweekly SDBN BUZZ podcast focused on connecting the region’s biotech community ... serve to promote the region and attract external employers, investors, scientists, and others ...
(Date:8/6/2019)... DEERFIELD, Ill. (PRWEB) , ... August 05, 2019 ... ... announced that Jason Casarella has been recognized as a distinguished leader by PharmaVOICE ... is featured in an article in the magazine’s July/August special issue. , As ...
(Date:8/4/2019)... ... 2019 , ... Cirtec Medical Corporation, a strategic outsourcing partner for complex medical ... construction on a 30,000 sq. ft. manufacturing facility in the Coyol free zone, ... facility, which is expected to be fully operational by the end of the year, ...
(Date:7/26/2019)... , ... July 25, 2019 , ... ... leaders through off-the-record collaboration and dialogue, today announces its Boston BD ... Hotel. As part of Biotech Week Boston , the event provides an ...
Breaking Biology Technology:
(Date:8/14/2019)... , ... August 14, 2019 , ... Join Jonathan Riek, ... session on Tuesday, September 10, 2019 at 1pm EDT to learn about two ... effective management. , NAFLD is the most common diffuse liver disease, with a ...
(Date:8/14/2019)... ... ... of Veterinary Medical Center of Fort Mill has recently begun providing VetStem ... geriatric Australian Shepherd, Simon, was treated in June 2019 for osteoarthritis in his shoulders, hips, ... weak, and he struggled to play fetch and other games with his family. He ...
(Date:8/6/2019)... ... , ... Keck Graduate Institute (KGI) President Sheldon Schuster has announced Martin Zdanowicz ... “Dean Zdanowicz is highly regarded as an innovative leader who prioritizes student success and ... choice to build on the success of the KGI School of Pharmacy and Health ...
Breaking Biology News(10 mins):